1-alkyl-2-acetyl-sn-glycetyl-sn-sn-glycerol cholinephosphotransferase
10-cell decrease
10-eo-cfu increase
12-week program of exercise
15-ml/min decrease
2-vessel cad
2-way anova
24-hour brachial systolic pressure
25.6kg/m
28-day mortality
3-vessel cad
30-day death/all-cause readmission
30-day readmission rates
30-day rehospitalization
3m potential preventable readmission
4-year survival
404.x3
6-minute walk test
70y
71 ml/m2
72-hour cumulative urine volume
8-fluo-camp binding
8.4 mm hg
8296 ml
84 ml/m2
8574 ml
95% confidence level
; onset hfref
aac
aas
abcd classification
abdominal aortic constriction
abdominal problems
abnormal body composition
abnormal ca(2+) handling
abnormal cardiac t2
abnormal exercise hemodynamic status
abnormal hr variability
abnormal liver texture changes
abnormal scn5a mrna splicing
abolished protein expression
abrogate pathological gene expression
absorption function
acc
acetyl-lysine reader proteins
acetylcholinesterase inhibition
acetylcholinesterase inhibitor pyridostigmine
acf
acp
acquired heart failure
acr
acs
acs problems
acs procedures
actin cytoskeleton
activators
active individuals
activity
acute
acute anthracycline-induced cardiotoxicity
acute autonomic nervous system modulation
acute care hospital
acute care surgery
acute coronary syndrome
acute coronary syndromes
acute decompensated hf
acute dyspnea
acute heart failure
acute heart failure clinical trials
acute heart failure trials
acute hf
acute hf diagnosis
acute hf trials
acute ischemic right heart failure
acute kidney injury
acute myocardial infarction
acute pulmonary embolism
acute right heart failure
acute rv decompensation
acute rv failure
acute treatment of heart failure
acute β-adrenoceptor blockade
acute β-ar stimulation
ad-c
ad-c rats
ad-flk
ad-flk rats
adaptive
adenine nucleotides
adenosine
adenoviral vector
adenyl cyclase
adherence
adipokines
adiponectin
adipose tissue
adjunctive treatment
adjusted hazard ratios
adjusted median rate ratio
adjuvant setting
administration of contrast agent
administrative databases
admission
admission median bnp levels
admission nt-probnp
admission to discharge
admissions per patient
adult male wistar rats
advanced chronic obstructive pulmonary disease
advanced chronic organ failure
advanced copd
advanced disease
advanced heart failure
advanced heart failure therapy
advanced human hf
adverse cardiovascular
adverse event rates
adverse events
adverse neurohormonal activation
adverse outcome
adverse outcomes
aerobic
aerobic exercise
aerobic exercise training
aerobic exercise training on peak oxygen consumption
af
af ablation
af patients
af type
af-free probability
african americans
afterload
afterload burden
age
age-
age-matched
aggressive dose uptitration
aggressive medical treatment
aggressive protocols
aging
aha
ahf
ai
aim
air pollution
akt
albumin level
albumin levels
alcohol related
aldactone evaluation study
aldosterone antagonism
aldosterone antagonist
aldosterone antagonist eplerenone
aldosterone antagonist therapy
aldosterone blockade
aldosterone receptor antagonists
alendronate
all-cause
all-cause hospitalization
all-cause medical hospitalization
all-cause mortality
all-cause readmission
allopurinol
allopurinol rats
alphalisa immunoassays
altered protein kinase
ambulatory
ambulatory heart failure trial
ambulatory hf patients
ambulatory icd patients
ambulatory patients
american
american college of cardiology
american college of cardiology/american heart association guidelines on evaluation and management
american college of physicians
american heart association
ami
ami mortality rates
ami patient
amino-terminal pro-b-type natriuretic peptide
amyloidotic pattern
anaerobic metabolism
anaerobic threshold
anecdotal
anemia
anemia treatment
anemic
anesthetized dogs
ang ii infusion
ang ii infusion mouse model
angeli
angii
angina
angiogenesis
angiography
angioplasty
angiotensin converting enzyme inhibitor
angiotensin converting enzyme inhibitors
angiotensin converting enzyme inhibitors intolerance
angiotensin ii
angiotensin ii infusion
angiotensin ii receptor blocker
angiotensin receptor antagonist valsartan
angiotensin receptor blockers
angiotensin receptor blockers therapy
angiotensin receptor neprilysin inhibitor
angiotensin receptors blockers
angiotensin-converting enzyme inhibitor
angiotensin-converting enzyme inhibitors
angiotensin-converting enzyme inhibitors/angiotensin receptor blockers
angiotensin-receptor block
angiotensin-receptor blockers
angiotensin-receptor neprilysin inhibitors
animal models
ankle-brachial index
ann arbor veterans' affairs hf clinic
annular size reduction
ans mice
antagomir
anterior leaflet opening
anthracycline
anthracycline exposure
anthracycline metabolism
anthracycline-containing chemotherapy
anthracycline-induced cardiotoxicity
anthracycline-related congestive heart failure
anthracycline-treated breast cancer patients
anti-flammatory effects
anti-neoplastic
anti-oxidant defence
antiarrhythmic drugs
antiarrhythmic medication
antibodies
antibodies targeting nonglycosylated
anticoagulants
anticoagulation
antihyperglycemic agents
antihyperglycemic drugs
antihypertensive medication
antiplatelet agents
antiplatelet drugs
antiplatelet medication
antitachycardia pacing
antitumor activity
aortic blood flow
aortic insufficiency
aortic pressure curve
aortic valve insufficientncy
aortic valve oversewing
aortic valve procedures
aortic valve repairs
aortic valve replacement
aortic valve surgery
aortocaval fistula
apex
apical
apical rotation
apoptosis
apoptotic cells
apoptotic signaling pathway
arg16/gln27
aric
aric hf
aric hf model
arm cuff
arni
arni inhibitors
arrhythmia
arrhythmia substrate
arrhythmias
arterial compliance
arterial elastance
arterial pressure
arterial tonometry study
ascending phase
astronaut
asymptomatic pediatric fontan
at
at1 receptors
atheromatous coronary disease
atherosclerosis
atherosclerosis risk
atherosclerosis risk in communities
atherosclerotic cad
athletes
atp
atp demand
atp production rates
atrial explant-derived c-kit
atrial fibrillation
atrial fibrillation/flutter
atrial structure
atrial tachyarrhythmias
atrioventricular delay
auc
aucs
augmented cyclic guanosine monophosphate
augmented feedback
auscultation
autologous
autonomic balance
autonomic dysbalance
autonomic modulation
autonomic nervous system activity
autonomica
avd
avp
b act via activation of vegf pathway
b on cardiac function
b-treated
b-treated rats
b-type natriuretic peptide
b-type natriuretic peptide levels
b-type np
baroreflex activation therapy
baroreflex sensitivity
barriers
barriers to exercise score
basal
basal contractility
basal heart rate
basal rotations
baseline
baseline characteristics
baseline ecgs
baseline echocardiography
baseline ef
baseline egfr group
baseline glomerular filtration rate
baseline hgb
baseline hrqol
baseline in peak oxygen uptake
baseline kccq scales
baseline nt-probnp
baseline sdqt-to-sdrr ratio
baseline serum creatinine level
baseline sst2 status
baseline st2 level
basic helix-loop-helix
bat
bax
bb
bb therapy
bcl-2
bcl-2 mrna expression
bcl-2 proteins
bcl-2/bax
bcl2
beagle dogs
beat-to beat qt intervals
beat-to-beat qt interval
beck depression inventory
behavioural-change interventions
bet bromodomain-containing protein 4
bet family bromodomain proteins
bet inhibition
beta blockade
beta blockers
beta receptor blockers
beta-blocker dose
beta-blocker hypo-response
beta-blocker therapy
beta-blockers
beta1-adrenergic receptor
bets
between
bhlh
bhlh transcription factor hand2
bioinformatic analysis
biological phenotype
biomarker
biomarker-guided clinical trial design
biomarker-guided clinical trials
biomarkers
biomedical reasons
biomedical treatment
bioprosthetic aortic valve replacement
bioprosthetic valve replacement
biosynthetic enzymes
bisoprolol
bisphophonates
bisphosphonate
bisphosphonates
biventricular dysfunction
biventricular pacing
biventricular support
bivp
black ethnicity
black patients
black race
blacks
bleeding
blockade
blood loss
blood pressure
blood pressure control
blood transfusions
blood urea nitrogen
blood work drawn
blood-flow paths
blunted cardiac β-ar responsiveness
blunts beta-adrenergic responses
bmi
bnp
bnp levels
bnp measurements
bnp/nt-pro bnp
body
body composition
body fat distribution
body mass
body mass index
body mass index ≥35 kg/m
body weight
borderline
both geometry
bottleneck shape
bottleneck stent
bottleneck stent model
bottleneck stenting
bradyarrhythmias
bradycardia induced
bradycardic response
brain natriuretic peptide
brd4
breakdown of atrial natriuretic peptide
breast cancer
breast cancer patients
breathing
breathing control
bridge to recovery infarction-related refractory right heart failure
bridge to transplantation
bridging therapy
bromodomain inhibition halts heart failure
bromodomain proteins
bt
btes
btt
bundle branch block electrical activation sequence
bundle-branch block
burden of heart failure hospitalizations
c statistic
c termini
c'd
c'd hf
c-index
c-kit+ cell phenotype
c-kit+ cell yield
c-kit+ cells
c-statistics
c-terminally processed forms
c-terminally truncated fragments
c57bl
ca(2+) handling
ca(2+) influx
ca(2+)-uptake
cachectic heart failure patients
cachexia
cad
calcineurin/nfat signalling
calcium-sensitizing agents
calf muscle
calif
caloric restriction
calreticulin
camp
camp hydrolysis
camp hydrolytic activity
camp levels
camp production
camp signaling
camp-dependent protein kinase
campbell collaboration
canadian cardiovascular society guidelines
cancer
cancers
candesartan in heart failure assessment of reduction in mortality
canine model of chronic heart failure induced
capillary
cardiac
cardiac amyloidosis
cardiac angiogenesis
cardiac apoptosis
cardiac arrest
cardiac autonomic balance
cardiac benign tumors
cardiac c-kit
cardiac cachexia
cardiac catheterization
cardiac chromatin
cardiac death
cardiac development
cardiac diameters
cardiac dysfunction
cardiac events
cardiac explant c-kit
cardiac explant-derived cells
cardiac failure
cardiac fibrosis
cardiac filling
cardiac filling pressures
cardiac function
cardiac functions
cardiac gene control
cardiac genes
cardiac growth
cardiac hypertrophic response
cardiac hypertrophy
cardiac hypertrophy secondary to pressure-overload
cardiac index
cardiac injury
cardiac insulin-resistance
cardiac insulin-restance
cardiac irs1
cardiac l-type channel activity
cardiac looping
cardiac magnetic resonance
cardiac magnetic resonance imaging
cardiac magnetic resonance postcontrast t1 time
cardiac magnetic resonance t1
cardiac mena deletion
cardiac mrna levels
cardiac murmurs
cardiac myocyte-specific mena overexpression
cardiac na+ current
cardiac nurses
cardiac output
cardiac pathogen
cardiac pathophysiology
cardiac patients
cardiac performance
cardiac plasma membrane levels
cardiac procedures
cardiac progenitor function
cardiac rehabilitation
cardiac remodeling
cardiac resynchronization
cardiac resynchronization therapy
cardiac specialty hospital
cardiac stress
cardiac sympathetic activity
cardiac sympathetic tone
cardiac symptoms
cardiac tissue
cardiac transplant
cardiac transplant (ecct
cardiac transplant survival
cardiac transplantation
cardiac troponin t
cardiac vagal
cardiac vagal tone
cardiac vegf expression
cardiac volume overload
cardiac-resynchronization therapy
cardiogenic shock
cardiologist
cardiology
cardiology practices
cardiology services
cardiology-cardiovascular surgery consensus report heart failure
cardiomyocyte bioenergetics
cardiomyocytes
cardiomyopathic restriction
cardiomyopathy
cardioprotection
cardioprotective effect
cardioprotective signaling
cardiopulmonary
cardiopulmonary exercise test
cardiopulmonary exercise testing
cardiopulmonary exercise variables
cardiopulmonary resuscitation
cardiorespiratory fitness
cardiotoxicity
cardiovascular
cardiovascular complications
cardiovascular conditions
cardiovascular death
cardiovascular disease
cardiovascular diseases
cardiovascular event rate
cardiovascular event-free rate
cardiovascular events
cardiovascular health
cardiovascular hospitalization
cardiovascular mortality
cardiovascular mortality/hf hospitalization
cardiovascular outcomes
cardiovascular risk factors
cardiovascular system
cardioverter-defibrillator
cardioverter-defibrillator deactivation preferences
care management
carotid bodies
carotid intima-media thickness
carvedilol
case-control study design
case-fatality rate
caspase
caspase 3 expression
caspase-3
caspase-3 activity
caspase-3 gene expression
catabolic isoenzymes
catabolic/anabolic imbalance
catalytic
catecholamine infusions
catheter ablation
catheter ablation for af
catheter ablation of atrial fibrillation
catheter-based percutaneous revascularization
cause
cause of systolic hf
cav1.2
cav1.3
cav1.3 channels
cc
cd133
cd34+vegfr2+ cells
ceballos
cell
cell adhesion genes
cell expansion protocols
cell senescence
cells
cellular dysfunction
cellular plasticity
center retrospective observational study
centers for medicare
centers for medicare and medicaid services
central blood pressure
central end-systolic pressure
central glycosylated region
central venous pressure
centrifugal flow pump
centrimag right ventricular assist device
centrimag rvad
cerebral blood flow
cf
cf devices
cf lvad patients
cfa
cfi
cgmp
cgmp synthesis
ch
chagas' disease
chamber patterning
channels
charm programme
chart review
chelation choices
chelation regimens
chemical instability
chemotherapy
chemotherapy-induced heart failure
chf
chf after hct
chf atrial explants
chf inhibition of avp
chf patients
chf predictive model
chf treatments
chf visit rates
chf-derived c-kit+ cells
chf-developed infarcted animals
chf-dnx
chf-inv
chf-inv group
chf-inv rabbits
chf-nyha-ii
chf-nyha-iii
chf-nyha-iiib
chf/lv dysfunction
childhood
childhood malignant disease treatment strategies
chinese herbal medicine
chm
choline
chop
chordal ruptures
chromatin
chromatin hyperacetylation
chromatin structure
chromatin subproteome
chromatin subproteomes
chromatin-associated proteins
chromatin-associated proteins extracted
chromatin-dependent signal transduction
chromatin-mediated signal transduction
chronic acf
chronic advanced heart failure patients
chronic decompensated heart failure
chronic disease
chronic end-stage heart failure
chronic heart failure
chronic heart failure chronic heart failure
chronic hf
chronic hf-ref
chronic hfpef
chronic inflammatory state
chronic insulin exposure
chronic kidney disease
chronic kidney disease epidemiology collaboration equation
chronic myocardial ischemia
chronic obstructive pulmonary
chronic obstructive pulmonary disease
chronic pah
chronic pulmonary arterial hypertension
chronic renal failure
chronic stable guideline-directed medical therapy
chronic systolic heart failure
chronic β-adrenergic receptor stimulation
chronic β-ar stimulation
chronic, stable hfpef
ci
ciaraldi
cinahl
circulating cd34
circulating forms of nt-probnp
circulating fragments
circulating mediator of insulin resistance
circulating nt-probnp
circulating nt-probnp concentration
circulating plasma ne
circulating progenitor cells
circulation of hf patients
circulatory derangement
circulatory support
citrate cycle
ckd
class i
class i recommendations
class ii
class ii heart failure
class iii
clcnka
clcnka gg genotype
clcnka polymorphism
clcnka snp
clin
clinical
clinical (prognostic
clinical care
clinical care delivery
clinical characteristics
clinical comparisons
clinical composite response
clinical deterioration of hfpef
clinical diastolic dysfunction
clinical doppler echocardiography
clinical effects
clinical excellence registry
clinical modification codes 404.x1
clinical outcome
clinical outcomes
clinical practice
clinical practice guidelines grading system
clinical prediction rule
clinical status
clinical status hospitalizations
clinical studies
clinical trial registries
clinical trials
clinical variables
clinician belief
clinician expertise
clinician interviews
cms
cms metric
cms metrics
co
co-activating transcription factor networks
co-morbidities
co-morbidity burden
coagulability
cochrane databases
cochrane effective practice
cochrane library
cogeneration of nitrite
cognitive function
cognitive impairment
cohort
cohort study
collagen cross-linking
collagen density
collagen deposition
collateral growth
colon
comanagement
commissioning
community outpatient settings
comorbidities
compensated hfpef
compensated lv hypertrophy
competing priorities
competing risk
competitive collateral growth patterns
compliance
complications after implantation
complications of therapy
composite end point of esrd
composite end-point of all-cause mortality
composite measure
computed tomographic angiography
computing readmissions
concentrations of soluble
concentric hypertrophy
concentric left ventricular hypertrophy
concentric remodeling
concurrent hf
conditional gene-targeted hand2 mice
conditions
conduction abnormalities
confidence interval
confirmatory factor analysis
congenital abnormalities
congenital accessory pathways
congenital heart lesions
congenital lesions
congestion-like
congestive heart failure
congestive heart failure exacerbation
congestive heart failure patients
congestive heart failure phenotypes
congestive heart failure trial
congestive heart failure visits
congestive symptoms
conjoint education
conscious rabbits
consensus report
construct validity
consultation
consultations
contemporary chronic heart failure
contemporary heart failure
contemporary therapeutic
content-driven telehealth system
content-driven telehealth technology
continuity equation
continuous flow
continuous nris
continuous wave doppler echocardiography
continuous-flow lvads
contractile efficiency
contractile function
contractile response
contractility
contrast agent
control
control adenovirus
control group
controlled randomized trial
controlled trial investigating outcomes in exercise training
controlled trial investigating outcomes of exercise training
controlling heart rate
conventional clinical
conversations
copd
coprimary end points
coral
coronary angiography
coronary angography
coronary arteries
coronary artery
coronary artery bypass grafting
coronary artery bypass surgery
coronary artery calcium
coronary artery disease
coronary artery ligation
coronary disease
coronary heart disease
coronary interventions
coronary microembolization-induced hf
coronary occlusion
coronary perfusion
correction
cost
cost analysis
cost-effective
cost-effectiveness
cost-effectiveness analyses
cost-effectiveness limits
costs
coupling
covariates
cox hazard models
cox model
cox models
cox proportional hazard analyses
cox proportional hazard models
cox proportional hazards
cox proportional hazards models
cox proportional hazards regression modeling
cox regression
cox regression analyses
cox regression analysis
cox regression models
cox-proportional hazard models
cpcs
cpet guiding exercise rehabilitation
cpg-recommended pharmacological treatment
cpgs
cpr
cr
creatine kinase activity
creatinine
crf
crf distribution
cronbach
cross-talk
crt
crt capability
crt group
crt implantation
crt off
crt on
crt on assignment
crt-d
crt-d recipients
crude
crude 28-day case-fatality rate
crude rates
crude rr
cs
ctnt
cultured cardiomyocytes
cumulative administration of doxorubicin
cumulative urine volume
current amplitude
currents
curve
cutoff
cutoff level
cutoff value
cv
cv death
cv deaths
cv events
cxl-1020
cxl-1020 converts
cystatin c level
cytochrome c
cytoscape
cytoskeletal actin dynamics
cytotoxic effect
czech republic
cα
dacron patch closure
danish heart failure database
danish registry on dialys
dapc
dapc protein levels
dash
dash diet scores
dash/srd
dash/srd reduced clinic
data
data monitoring board
data processing
dcm
dd
deactivation
death
death/hospitalization/ed visit
debilitating chronic disease
debilitating stroke
decline in ejection
decompensated systolic heart failure
decongestion
decongestion end point
decoy vegf receptor
decrement of heart rate
defects
defibrillator
defibrillator-only therapy
deficit index
deficits
degenerative mitral regurgitation
degenerative mr
degs
delayed rhythm control
demographic
demographics
department of cardiology
depressed left ventricular
depression
deranged ca(2+) handling
derivation cohort
descriptive assessment
descriptive research
desensitizes against acute β-ar stimulation
design
destination therapy
detergent
development
development and evaluation
developmental chromatin remodeling events
developmental impairment
device
device consideration
device implantation
devices in heart failure
diabetes
diabetes mellitus
diabetes status
diabetic zsf1 rats
diagnostic
diagnostic performance
diagnostic procedure
diagnostic procedures
diagnostic roles
diagnostic test
dialysis
dialysis patients
dialysis-dependent patients
diameter stenosis
diastole
diastolic
diastolic blood pressure
diastolic dysfunction
diastolic failure
diastolic filling time
diastolic function
diastolic indices
diastolic mitral leaflet motions
diastolic mitral valve tethering
diastolic properties
diet
diet group
diet score
dietary approaches to stop hypertension
dietary interventions
dietary recommendations
dietary sodium restriction
differential analysis
differential g-protein coupling
differential relations
diffuse myocardial changes
dilated cardiomyopathy
dilated poorly contracting ventricles
diminished cyclic adenosine monophosphate
dipeptidyl peptidase-4
direct interaction
direct observation
direct renin inhibitors
disappearance of mr
discharge
discharged patients
disclosing prognosis
discrimination
discrimination improvement
disease
disease complex
disease management
disease management programs in heart failure
disease recapitulates
disease risk score
disease-specific costs
diseased cardiomyocytes
diseased human
diseased mouse heart
distance
distance walked
distressing implantable cardioverter-defibrillator shocks
disturbed intestinal barrier
dithiothreitol
diuretic
diuretic efficacy
diuretic peptides
diuretic refractory severe-end-stage hf
diuretic resistant volume overload
diuretic therapy
diuretic use
diuretics
divergent etiology
dna
dna fragmentation
dnx
dobutamine
doctor
doctors
dodson
donors
dopamine
doppler early diastolic mitral annulus velocity
doppler mitral inflow velocity
doppler ultrasonography
dose uptitration
dose-related gradient of hf risk
double mutant
double-blind
downregulated
downregulation
downstream of β-adrenergic receptor activation
downstream signaling
downstream signalling
downward regression line shift
doxorubicin
doxorubicin cardiotoxicity
doxorubicin in vitro
doxorubicin-induced cardiotoxicity
doxorubicin-induced heart failure
dpp-4
dpp-4 inhibitors
driveline infection
driveline injury
drs deciles
drs-stratified analyses
drs-stratified hazard ratios
drug abrogated
drug dose
drug-free
drug-untreated failing hearts
dt
dtt
dual energy x-ray absorptiometry
dual x-ray absorptiometry
dual-energy x-ray absorptiometry
duration
dxa
dynamic
dysfunction
dyslipidemia
dyspnea
dyssynchronous failing heart
dyssynchronous heart failure
dyssynchronous hf
dyssynchronous nonfailing
dystrophin-associated protein complex
e-septal correlated
e-wave
e/e
e/e'lateral
e/e'mean
e/elateral
e/emean
e/eseptal
ea
early
early risk of stroke
early transmitral blood flow velocity
early transmitral flow
early-onset
early-onset hf
early-outgrowth colony-forming units
east
ec
ec coupling
ec/e
eccentric hypertrophy
ecct
ecct patients
ecg
ecg parameters
echo-doppler cardiography
echo-doppler studies
echocardiograms
echocardiographic
echocardiographic assessment
echocardiographic evidence of left ventricular dyssynchrony
echocardiographic examination
echocardiographic measurements
echocardiographic measures
echocardiographic predictors
echocardiographic score
echocardiographic systolic parameters
echocardiography
echocardiography evaluations
ecmo
ecmo group
ecmo+vad group
ecmo+vad groups
ecntric
economic
economic analysis
economic climate
economic evaluations
economic impact
economic models
economic savings
ecs
ed
ed patients
ed physicians
ed visits
ed volume influences patient outcomes
edge-to-edge anastomosis
ees
ef
ef ≤30%
effector molecules
efficiency
egfr
egfr group
eh
eh denotes
ejection fraction
ejection fractions
elastic n2bus segment
elateral
elderly
elderly patients hospitalized
electrical activation
electrical stimulation
electrocardiographic device
electrocardiographic q waves
electrolytes
electromechanical behavior
electromechanical delay
electron microscopy
electronic databases
elevated left atrial pressure
elevated resistin
elevated resistin levels
elevations
embase
embryonic gene programs
embryonic gene programs in heart failure
emd
emd prolongation
emergency
emergency cardiac catheterization
emergency department
emergency department volume
emergency room practice
emotional status
emotional stress
emphasis-hf
emphasis-hf study
empirically derived composite quality measure
end point of death
end stage heart failure
end stage kidney failure
end-diastolic volume
end-diastolic volume index
end-of-life treatment preferences
end-stage congestive heart failure
end-stage heart failure
end-stage renal disease
end-systole
end-systolic elastance
end-systolic volume
end-tidal co2
endoplasmic reticulum
endothelial cell
endothelial dysfunction
endothelial function
endothelial no synthase activation
endothelial repair
endothelial-protective effects
endothelin
energy deficit
energy expenditure
energy metabolism
energy substrate metabolism
english-language trials
enhanced catabolism
enos-ser(1177
enos-thr
enrollment
enrollment period
enrollment periods
eo-cfus
eov
epicatechin-rich cocoa
epidemic
epidemiology
epifluorescence microscopy
epigenetic
epigenetic changes
epigenetic readers in cardiac biology
epinephrine
epithelial
eplerenone
eplerenone in mild patients hospitalization
eplerenone post myocardial infarction heart failure efficacy
erasers
erc
erc induced recovery
erk1/2 molecular scaffolds
erk1/2 signalling
erythropoiesis-stimulating agent therapy
erythropoiesis-stimulating agents
esc advocate
eseptal
esmolol
esrd
et
et on hdl-mediated protective effects
ethically
ethics rounds
etidronate
etidronate-
etiologic
etiology
eu
eu exerts beneficial effects
european hf guidelines
european society of cardiology guidelines
euthanization
event rate
evidence based practice centres
evidence-based
evidence-based medications
evidence-based treatments
exacerbates heart failure
excessive secretion of arginine vasopressin
excitation-contraction
exercise
exercise adherence
exercise attendance
exercise capacity
exercise duration
exercise group
exercise intolerance
exercise modality
exercise oscillatory ventilation
exercise performance
exercise performance in recent onset heart failure
exercise programmes
exercise rehabilitation
exercise time
exercise tolerance
exercise training
exercise training on hrqol
exercise-induced pasp
exercise-induced pasp increase
exercise-induced pulmonary artery systolic pressure
exertion
exertional
exogenous variants induced upr
expenditure
expenditures
experimental hf
experimental research
explant-derived progenitor cells
exploratory factor analysis
expression
extending emd
external validity
extracellular flux analyzer
extracellular matrix
extracorporeal life support
extracorporeal membrane oxygenation
extracorporeal membrane oxygenation membrane support
extracorporeal support
extreme deciles
extreme n
extubated
factorial trial
factors
failing fontan
failing heart
failing hearts
failure
failure of cardiovascular reserve
familiar physician
families
family
fat loss
fat mass
fat mass index
fat/lean body mass ratio
fatal
fatigue
fatty acids
feasibility
female
fes
fetal gene program
few treatments
ffm
fiber/sheet orientation
fibrosis
figure
figures
filling formalism
filling pressures
financial burden
financial costs
first hf hospitalization
fit
fixed-rate atrial pacing
flow-mediated dilatation
fluid retention
fluorescence resonance energy transfer-based assays
fm
follow up body weight
follow-up
follow-up data
follow-up echocardiograms
follow-up exercise capacity
follow-up measurement
follow-up medication list
follow-up visits
fontan adults
fontan circulation
fontan failure
force generated
forkhead box
four-week aerobic training
fractional flow reserve measurements
fractional shortening
frail
frailty
framingham
framingham heart study criteria
free wall cs
free wall rs
free-breathing pulse sequence
full medicare coverage
full-length scn5a
fully magnetically levitated centrifugal-flow chronic lvas
fully magnetically levitated lvas
function
function in vitro
functional abnormalities
functional capacity
functional class nyha ii-iii
functional decline
functional deficits
functional electrical stimulation
functional enrichment analysis
functional mitral stenosis
functional ms
functional status
furosemide dose
futility
future mortality
g-protein-coupled receptor kinase-2
g-protein-coupled receptors
gadolinium-chelate contrast agent
gastrointestinal bleeding
gating movement
gdmt
gdmt-treated nyha
gem/kir
gender-matched control
gene expression
gene expression omnibus
gene expression profile gse9128
general anaesthesia
general hospital
general linear models
general population
genes
genetic
genomic reprogramming events
gill index
global attenuation
global gene expression
global left ventricular longitudinal systolic strain
global longitudinal strain
global longitudinal strain of left ventricle
global proteomics
glomerular filtration rate
gls
gls outperformed left ventricular ejection fraction
glucose
glucose oxidation
glucose transporter
gly16/glu27 haplotype
glycolysis
glycolysis/gluconeogenes
goal-directed lipid-lowering therapy
grade
grading of recommendations assessment
gross income
gross morphological
gross national income per capita
grounded theory
gtpase rac1 activity
guideline recommendations in heart failure
guideline-recommended drugs for heart failure
guideline-recommended medications
guideline-recommended treatment
guidelines
guidelines-heart failure
gut
h-dko mice
haard ratio
habc battery
habc battery score
habc battery scores
haematopoietic cell transplantation
haemodynamic
haemodynamic outcomes
haemodynamic stress
hall walk distance
hand grip strength
hano donor
hart
hart enrolled 902 patients
hatasis
hazard ratio
hazard ratio (hr
hct
hdl
hdl function
hdl(nyha-iiib
hdl-bound malondialdehyde
hdl-induced no production
hdl-mediated vascular effects
health
health abc hf model
health abc hf risk model
health abc short physical performance battery
health behaviors
health buddy program
health care expenditures
health insurance
health per capita
health service provision
health status
health system data partners
health-related
health-related quality of life
healthcare common procedure codes
healthcare utilization effects
healthstar
healthy cardiomyocytes
healthy control
healthy controls
healthy volunteers
heart
heart association classification
heart beat
heart block
heart dilatation
heart disease
heart failure
heart failure adherence
heart failure admission
heart failure aldosterone
heart failure attributable
heart failure care
heart failure clinic outpatients
heart failure discharges
heart failure disease management programs
heart failure guidelines
heart failure home
heart failure hospitalization
heart failure mice model
heart failure mortality
heart failure myocardial tissue
heart failure nurse practitioner
heart failure nurses
heart failure patient severity index
heart failure patients
heart failure prone
heart failure rats
heart failure risk
heart failure scans
heart failure t1-mapping values
heart failure treatment
heart failure-related hospitalization
heart failure-related mortality
heart function clinic
heart iron
heart magnetic resonance imaging
heart mass
heart muscle cells
heart pathology
heart rate
heart rate reduction
heart rate response
heart rate variability
heart rate variation
heart t2
heart team
heart transplant
heart transplant recipients
heart transplantation
heart transplantations
heartmate 3 left ventricular assist system
heartmate ii
heartmate ii exchange
heartmate ii implantation
heartmate ii insertion
heartmate ii lvad
hearts
hearts of ans mice
hearts of fish lacking nucleolin
heartware
heartware intl
hek
hemocompatibility
hemodynamic
hemodynamic alterations
hemodynamic perturbations
hemodynamic phenotype
hemodynamic status
hemodynamically
hemodynamically unstable
hemoglobin
hemoglobin levels
hemostasis
hepatic function
hereditary
heterochromatic chromatin
hf
hf admissions
hf canine electromechanics
hf cases
hf clinic outpatients
hf cohort
hf complicating ami
hf epidemiology
hf hospital admissions
hf hospitalisations
hf hospitalization
hf hospitalizations
hf hospitalized
hf induced
hf infancy
hf mortality
hf mortality risk
hf pathogenesis
hf patients
hf progression
hf rats
hf readmissions
hf registry
hf remodeling aspects
hf resources
hf risk
hf risk factors
hf risk prediction
hf studies
hf symptom
hf therapy
hf under drug treatment
hf units
hf volume management
hf-action
hf-action cohort
hf-induced remodeling aspects
hf-ref
hf-related cachexia
hf-related morbidity
hfpef
hfpef patients
hfpsi
hfpsi model
hfref
hfref therapy
hfvt
hg
hg β coefficient
hgb
hgb level
hh
hhd
hhf
high
high bnp
high bnp group
high morbidity
high mortality
high muscle strip stiffness
high risk of hyperkalemia
high sst2/high-dose bb
high-cost medicare beneficiaries
high-density lipoprotein
high-dose bb
high-fat diet
high-frequency
high-risk patient
high-risk patients
high-risk subgroups
high-sensitivity assay
high-volume eds
high-volume physicians
higher hemoglobin levels
hipsc-cms
histological
histological analysis
histone acetyltransferases
histone deacetylases
hm
hm ii
hno
hnorm
hnorm group
hnorm groups
hogan
holosystolic murmur
home telemonitoring
hospital
hospital admission
hospital days
hospital discharge
hospital length
hospital mortality
hospital performance
hospital readmission reduction program
hospital volume
hospital-based programmes
hospitalisation
hospitalisations
hospitalization
hospitalization for heart failure
hospitalizations
hospitalized
hospitalized heart failure
hospitalized hf
hospitalized older adults
hospitalized patients
hospitals
hr
hr dynamics
hr per kg/m
hr reduction
hr variability
hr variability/turbulence
hretn
hrqol
hrv
hscrp
hum-retn mice
human
human embryonic kidney
human failing hearts
human heart failure
human hf
human induced pluripotent stem cell-derived cardiomyocytes
human monocytes
human myocardial tissue
human rad q66p
human resistin
human resistin mrna
human retn gene
human ventricular systolic hf tissue samples
human-to-human contact
human-to-machine interface
humanized male mice
humanized mouse model lacking murine resistin
humoral stimuli
hungary
hvad devices
hyperinsulinemia
hyperkalemia
hyperlipidaemia
hypertension
hypertensive
hypertensive heart disease
hypertensive heart failure
hypertensive hfpef
hypertensive lv dysfunction
hypertrophied heart
hypertrophy
hypoalbuminemia
hypokalemia
hypotension
hypothermic circulatory arrest
hypothesis-generating findings
hypoxia
i
i-meta-iodobenzylguanidine
i-mibg
i-mibg cardiac washout
i-mibg myocardial washout
ic
ic enrolled
icc
icd patients
icd shocks
icd-hf patients
icds
icu
icu admission
icu mortality
idealized lv end-diastolic pressure
idiopathic dilated cardiomyopathy
idiopathic dilated cardiomyopathy cohort
idiopathic-dilated cardiomyopathy
ie
ie risk
if inhibitor ivabradine trial
if-channel inhibition
iii
il6
immunoassays
immunoblotting
immunodetection
immunohistochemistry
immunoprecipitation
immunoreactive nt-probnp
impact of frailty
impaired cardiac energy metabolism
impaired cardiac metabolic gene expression
impaired lv relaxation
impaired right ventricular pump function
impaired systolic function
implantable cardiac arrhythmia devices
implantable cardiac defibrillator
implantable cardioverter defibrillator-crt
implantable cardioverter defibrillators
implantable cardioverter-defibrillator
implantable cardioverter-defibrillator deactivation
implantable cardioverter-defibrillator deactivation discussions
implantable cardioverter-defibrillator device
implantable cardioverter-defibrillators
implantable defibrillators
implantation
implanted monitoring devices
implementation interventions
implementation strategies
in conjunction
in vivo coronary perfusion
in vivo inhibition
in vivo rv length-force relationship
in-trial resource utilization
inactive cxl-1051
inappropriate atp
inappropriate implantable cardioverter-defibrillator therapy
inappropriate shock therapy
inappropriate therapy
incessant ventricular tachycardia storm
incidence
incidence and mortality outcomes of heart failure
incidence of and deaths attributable
incident cardiovascular events
incident hf
incident systolic heart failure
incubation of ec
index
index ami
index beat method
index ed visit
index hf
indices
inducible myocardial ischemia
inducing hyperkalemia
industrial areas
infarct size
infarcted hearts
infarcted rats
inflammation
inflammation-stimulated resistin levels
inflammatory
inflammatory abdominal problems
inflammatory biomarkers
inflammatory markers
inflammatory stimuli
ingenuity path
inhibition of vascular endothelial growth factor
inhibitor jq1
inhibitory actions
inhospital mortality
inhospital outcomes
initiative
inoperable chronic thromboembolic pulmonary hypertension
inotrope
inotropes
inotropic
inotropic effect
inpatient admissions
inpatient medical conditions
inpatient records
institution of pd
insulin action
insulin receptor substrates
insulin resistance
insulin-signaling components regulating cellular metabolism
insulin-stimulated rates
insurance status
intact hearts
interaction term analysis
interagency registry for mechanically assisted circulatory support
interatrial shunt
interest
interleukin receptor family member st2
intermediate frailty
intermediate metabolism
intermuscular fat ratio
internal
internal consistency
international classification of diseases
international right heart foundation working group
internists
interquartile range
intervention
intervention compliance
interventions
interventricular delay
interventricular septum biopsies
intestinal dysfunction
intestinal morphology
intracellular antiadrenergic strategy
intraclass correlation coefficient
intramuscular testosterone supplementation
intravenous atropine
intravenous bolus of metoprolol
intravenous inotropes
intravenous iron
intravenous metoprolol
intrinsic left ventricular dysfunction
intubation rates
intubations
invasive haemodynamic assessment
invasive hemodynamic
invasive hemodynamic assessment
ion channelopathies
ip
iron
iron deficiency
iron homeostasis
iron use
iron-deficient adult patients
irs1
irs2
irs2 double-knockout
irs2 proteins
is
ischemic
ischemic cardiomyopathy
ischemic etiology
ischemic events
ischemic heart failure
ischemic heart failure samples
ischemic hf pathogenesis
ischemic mitral regurgitation
ischemic mr
ischemic-hypertensive cardiomiopathy
isoelectric focusing
isolated cardiomyocytes
isolated heart rate
isolated heart transplant
isolated heartmate
isolated heartmate ii lvad
isolated hr reduction
isolated myoctyes
isolated working hearts
isoprenaline infusion
isoproterenol
iv heart failure
iv hf
ivabradine
ivabradine group
ivabradine unloads
ivc
ivc occlusion
japanese heart failure
jehovah
jehovah's witness
joanna briggs institut
joint-methods study
jq1
jugular venous pressure
ka renal chloride channel gene
kansas city cardiomyopathy questionnaire
kaplan-meier
kaplan-meier curves
kappa coefficient
kccq
kccq domains
kccq overall summary
kccq summary scores
kcl-ki treatment
kidney index score
kidney infection
killip class
kinases
kv4.3 channel mrnas
kv4.3 mrna levels
l-dko
l-dko mice
l-type ca2
l-type channel isoforms
l-type currents
l-type voltage-gated ca(2+) channels
label-free shotgun proteomics
laboratory
laboratory report
laboratory report model
laboratory variables
lack of correlation
lack of hypertension
lactate
lad
lad model 4 wk
lad models
lancet
late-activated lateral wall
late-onset
late-onset hf
latin america
lbbb
lcx
lcx model
ldl-cholesterol
leaflet configurations
leaflet motion
leaflet repair
lean mass
lean mass quantification
lean zsf1
lean zsf1 group
left
left and right ventricular assist devices
left anterior descending coronary artery occlusion
left atrial area
left bundle branch block
left heart twist
left ventricle
left ventricle end-diastolic pressure
left ventricular
left ventricular assist device
left ventricular assist device implantation
left ventricular assist devices
left ventricular base
left ventricular biopsies
left ventricular diastolic end diameter
left ventricular diastolic function
left ventricular dilatation
left ventricular dysfunction
left ventricular ejection fraction
left ventricular ejection time
left ventricular end-diastolic pressure
left ventricular filling
left ventricular filling pressure
left ventricular filling pressure response
left ventricular longitudinal systolic
left ventricular mechanics
left ventricular midpapillary level
left ventricular systolic
left ventricular systolic dysfunction
left ventricular tissue
left-hand grip strength
leg strength
length of stay
length-force relationship
leu3-gly4
leukocytes
level of agreement
lf/hf ratio
liberal transfusion protocols
life expectancy
life-sustaining treatment
lifesaving drugs
limitation
limits of agreement
lipolysis
lipoprotein-associated phospholipase a2
literature
littermate controls
liver
liver disease
load-corrected chronotropic response
local myocyte depolarization
log rank
log-rank testing
logistic analysis
logistic regression analysis
logistic regression models
lokomat system
lokomat® system
long axis function
long-acting insulin products
long-standing persistent persistent af
long-term mortality
long-term survival
long-term ventricular assist device
longitudinal outcome-monitoring phase
longitudinal rv fiber shortening
loop diuretics
low crf categories
low egfr
low left ventricular ejection fraction
low left ventricular ejection fractions
low pasp
low testosterone status
low-dose bb
low-dose dopamine
low-dose nesiritide
low-frequency
low-risk group
low-sodium dash
low-volume ed cases
low-volume eds
low-volume institutions
low-volume physicians
lower body mass index
lower cd34+vegfr2
lower lvef
lp-pla2
lung weight
lusitropic
lv
lv assist device
lv assist device implantation
lv assist device implantations
lv compliance
lv contractility
lv diastolic dysfunction
lv diastolic stiffness
lv dilatation
lv dysfunction
lv ef
lv ejection fraction
lv end systolic volume index
lv end-diastolic dimension
lv end-diastolic pressure
lv end-diastolic pressure/wall stress
lv end-diastolic volume
lv end-systolic volume
lv fibrosis
lv filling pressure
lv filling pressures
lv fractional shortening
lv function
lv hypertrophy
lv internal diameter
lv mass
lv posterior wall thickness
lv remodeling
lv reverse remodeling
lv size
lv strain
lv strain rate
lv strain/strain rate
lv structure
lvad
lvad implantation
lvad insertion
lvad support
lvad surgery
lvad therapy
lvads
lvas
lvas support
lvef
lvet
lvet carries
lvh
lying
lyso-paf acetyltransferase
lyso-paf-at
macrophages
mad-crt study
madit-crt
madit-crt trial
magnetic resonance angiography
magnetic resonance spectroscopy
magnetically levitated rotor
magneticically levitated left ventricular assist system for treating advanced hf
main outcome measure
maintenance of sinus rhythm
maisel
maladaptive cardiac remodelling
male sex
malfunctioning heartmate ii lvads
malignancies
malondialdehyde bound
mammalian
mammalian enabled
management
management of end stage heart failure
management of gastrointestinal bleeding
management of heart failure
management strategies
markers of skm growth/differentiation
mass spectrometric analysis
mass spectrometry
massive embolism
matched cohort study
matched controls
maximal cardiopulmonary exercise test
mdc
mdc95%
mean ejection fraction
measurement value
measures of quality
mechanical
mechanical cardiac
mechanical cardiac support
mechanical circulatory support
mechanical dyssynchrony
mechanical support devices
mechanism enrichment analysis
mechanism of action
mechanisms
median age
median body mass index
median follow up
median followup
median followup duration
median left ventricular ejection fraction
median rate ratio
medicaid 30-day readmission
medicaid services demonstration
medical hospitalization
medical management
medical outcomes
medical records
medical resource use
medical support
medical therapies
medical therapy
medical treatment
medical treatment for heart failure
medical treatment guidelines
medicare
medicare fee-for-service beneficiaries
medicare fee-for-service beneficiaries discharged to skilled nursing facilities
medicare inpatient data
medicare patient safety monitoring system
medication
medication regime
medications
mediterranean
medline
mena
mena expression
mena overexpression
mesenchymal transition markers
meta-analyzed mortality
metabolic changes
metabolic enzymes
metabolic exercise
metabolic risk factors
metabolism
methotrexate
methylatropine
metoprolol
metoprolol on inappropriate implantable cardioverter-defibrillator therapy
metoprolol treatment
metric choice
mi
mi characteristics yielded hazard ratios
mi diagnosed
mi-induced decreases
mice
microarray data
micrornas
micrornas in heart failure
mid lad
middle-aged recreational athletes
midpapillary
midregional proanp
mild heart failure
mild mr
mineralocorticoid receptor antagonists
minnesota
minnesota living with heart failure
mir-25
mir-25 expression
mirnas
misdiagnosis of heart failure
mistargeting
mitochondrial complex v activity
mitochondrial damage induced
mitochondrial dysfunction
mitochondrial energy production
mitochondrial function
mitochondrial oxidation
mitochondrial oxidative metabolism
mitochondrial oxidative phosphorylation capacity
mitochondrial oxidative stress induced
mitochondrial proteome changes
mitochondrial respiration
mitochondrial structure
mitochondrial ultrastructural changes
mitochondrial-targeted antioxidant
mitochondrial-targeted peptide drugs
mitochondrial-targeted peptide ss31
mitochondrial-targeted peptides
mitral annulus velocities
mitral filling flow
mitral filling flow volume
mitral regurgitation
mitral stenosis
mitral stenosis reversed
mitral valve area
mitral valve opening
mitral valve plasty
ml/kg/min
mlhf
mlhf total score
moderate
moderate heart failure
moderately dilated lv
modifiable risk factors
molecular biomarkers
molecular dysfunction
molecular mechanism
molecular pathways
monoclonal antibodies
monomeric g proteins
morbidity
morpholino-based knockdown of nucleolin
mortality
mortality predictors
mortality rate
mortality risk
mortality/hospitalization
mouse heart failure
mouse hearts
mouse hf model
mouse myocardium
mouse rad q65p
mouse tac model
mouse ventricular myocytes
mpsms
mr
mr-proadm
mr-proanp
mri scanner
mri-based models
mrna level
mrna levels
mrna splicing
ms
mt
multicenter automatic defibrillator implantation
multicenter automatic defibrillator implantation trial-cardiac resynchronization therapy
multihospital study
multiorgan failure
multiple myeloma
multisystem disease
multivariable cox modeling
multivariable-adjusted hazard ratios
murine equivalent
murine myocardium to heart failure
murphy
muscle aerobic capacity
muscle strength
muscle strips
muscle-wasting syndrome
muscular strength
mutant mice overexpressing hand2
mva
myocardial
myocardial angiogenesis
myocardial collage
myocardial collagen
myocardial dd
myocardial diastolic dysfunction
myocardial extracellular matrix
myocardial extracellular matrix accumulation
myocardial fibrosis
myocardial function
myocardial glycolysis
myocardial infarction
myocardial infarction-both
myocardial insulin resistance
myocardial ischaemia
myocardial ischemia
myocardial ischemic events
myocardial loss
myocardial oxygen consumption
myocardial pde2
myocardial pde2 expression
myocardial perfusion
myocardial phosphodiesterase-2
myocardial remodelling
myocardial t1
myocardial t1 changes
myocardial tissues
myocardial titin hypophosphorylation
myocarditis
myocardium
myocardium displays altered expression
myocyte
myocyte diameter
myocyte differentiation
myocyte hypertrophy antecedent to heart failure
myocytes
myofiber dynamics
myofiber shortening
myofiber shortening onset
myofiber shortening velocity
myofibre regeneration
myofibrillar ca(2+)-stimulated atpase activity
myofilament ca(2+) sensitivity
myosin binding protein-c phosphorylation
myxomas
n-
n-terminal fragment
n-terminal pro-b-type natriuretic peptide
n-terminal pro-b-type natriuretic peptides
n-terminal pro-b-type np
n-terminal pro-brain natriuretic peptide
n-terminal pro-brain-type natriuretic peptide assessment
n-terminal probnp
na+
na+ channel mrna splice
nad(p)h-oxidase subunit rac2
nafat
nanomolar doses
narrow qrs complex
national cardiovascular disease registry practice innovation
national medicare
national patient safety initiatives
natremia
natriuretic peptide
natriuretic peptide levels
natriuretic peptide system
natriuretic peptides
natural vasodilatory
naturally occurring rad variant
naviaux
nbdmard
nbdmards
need of diuretics
negative binomial regression models
negative coronary angiography
negative cross talk
negative likelihood ratio
negative predictive value
neoangiogenes
neonatal rat ventricular cardiomyocytes
nephrectomy
nephropathy
neprilysin blocks renin-angiotensin-aldosteron
neprilysin inhibition
neprilysin inhibitor prodrug
neprilysin inhibitors
nesiriti
nesiritide
net reclassification
net-reclassification-improvement
network meta-analys
neuro-hormonal system
neurohormonal abnormalities
neurohormonal stimulation
neurohormonally induced heart disease
neurohormone
neurohormones
neurohumoral blockers
neurological
neuronal stressors
neutral endopeptidase inhibitors
new onset heart failure cellular responses to heart failure
new york heart association
new york heart association class
new york heart association class i to iii
new york heart association class ii
new york heart association class iii
new york heart association class iii heart failure
new york heart association classes
new-onset post-lvad
newly diagnosed heart failure
nf-κb
nfat
ng/ml
nhs
nicorandil
nicorandil ameliorates mitochondrial dysfunction
nights
ninth revision
nitric oxide
nitric oxide donors
nitroxyl
no
no production
noc outcomes
non-aas
non-biological disease modifying antirheumatic drug
non-cachectic chf
non-diabetic patients
non-dilated left ventricle
non-dnx
non-fatal stroke
non-frail participants
non-ischemic
non-ischemic heart failure samples
non-lbbb
non-linear hr variability
non-sudden cardiac death
non-urbanized midwestern state
nonadherence
noncardiac
noncardiologist
noncardiovascular diagnoses
noncardiovascular drugs
noncoding rnas
nondiabetes risk factors
nondiabetic patients
nonfatal outcomes
nonischemic cardiomyopathies
nonpace
nonpace dnx
nonprescribing
nonselective
nonsurvivors
nonterminal epitopes
nontrastuzumab
nontraumatic death
nontreatment
nordic walking
nordic walking led
norepinephrine
norepinephrine-induced hypertrophic responses
normal albumin levels
normal geometry
normal sized lv
normalization of albumin levels
northwest united states
np
np assessment
np levels
np measurement
nps
nt-probnp
nt-probnp assay
nt-probnp cutoff point
nt-probnp levels
nt-probnp testing
nuclear factor of activated t cells
nuclear factor-κb
nucleolin
nurse assessment of cognitive impairment
nurses
nursing outcomes classification
nursing-sensitive outcome change scores
nursing-sensitive outcome measures
nutrition
nutritional abnormalities
nutritional strategies
nuts
nyha
nyha class
nyha classification
nyha functional class ii
nyha functional class iv
nyha-iiib
o-1 signaling
o2 consumption rate
obese
obese older patients
obese participants
obese zsf1
obese zsf1 groups
obesity
occluded stent
occurrence
odds ratio
odds ratios
off-pump sternal sparing approach
office hours
office of statewide health planning and development patient discharge data
office-based
oht
oht bridged to transplant
older patients
olmsted county
ontario case costing initiative
open chest model
open stent
open surgery
open-label crossover study
operation
operationalized hospital quality of care outcomes
oral glucocorticoid
oral glucocorticoids
organisation of care taxonomy
orthotopic heart transplantation
osprey
osteoporosis
outcome
outcome in heart failure patients
outcome ratings
outcomes
outcomes after cardiac resynchronization therapy
outpatient
outpatient assessments
outpatients
overexpress scn5a variants
overstimulation
overweight
oxidative stress
oxidative stress markers
oxygen consumption
oxygen flow
oxygen pulse
p
p.arg83gly
p3 prolapse
p38
p38alpha mapk
p38α mitogen-activated protein kinase
p70s6k
p70s6k-ser
pace dnx
pace non-dnx
paced myocardium
pacemaker
pacemakers
pacing-induced chf
pacing-induced dilated cardiomyopati
paco2
pad
paediatric cardiac transplants
paediatric heart failure
paf
paf biosynthetic enzymes
paf levels
paf-acetylhydrolase
paf-ah
paf-cpt
pah
palliative care
paradigm-hf
parallel-group
parasympa
parasympathetic activity
parasympathetic function
parasympathetic neurotransmission
parasympathetic tone
partial pressure
participants
pasp
pasp increase
pasp relationship
passive/stiffness
pathobiology/pathophysiology
pathogenesis
pathogenesis of heart failure
pathological cardiac gene expression programme
pathological changes
pathological gene induction
pathological heart disease
pathological hypertrophy
pathological remodelling
pathophysiological
pathophysiological origin
pathophysiology
pathway alterations
patient
patient aged
patient compliance
patient consultation
patient management interventions in heart failure cost-effectiveness model
patient preferences
patient safety
patient satisfaction
patient-level regression
patients
patients admitted
patients discharged
patients enrolled in heart failure
patients in heart failure
patients undergoing procedures
patients with heart failure
pay-for-performance
pb
pb characteristics
pb cycle
pcwp
pcwp estimation
pd
pd initiation
pde superfamily
pde2
pde2 activity
pde2 inhibition
pde2 overexpression
pde2-mediated effects on beta-adrenergic receptor
pde2-overexpressing cardiomyocytes
peak aerobic capacity
peak consumption
peak early diastolic mitral annular velocity
peak early diastolic mitral flow velocity
peak o2 per kilogram
peak oxygen consumption
peak oxygen uptake
peak quadriceps force
peak vo2
peak work rate
peakca(2+) transient
pediatric heart failure
pediatric mechanical cardiac support
pediatrics
pef
penalties
perceived benefit
percent lean body mass
percutaneous coronary intervention
percutaneous coronary revascularization
percutaneous one-vessel model
performance
perfusion
perioperative
peripheral abnormalities
peripheral arterial disease
peripheral artery disease
peripheral muscle pump
peripheral muscles
peripheral oedema
peripheral vascular disease
periprocedural
periprocedural deaths
peritoneal dialysis
perk
perk activation destabilized scn5a
perk inhibition
perkins
permeability
perturbed bone morphogenetic protein 4 expression
perturbed mitochondrial function
petco2
pevk segment
pf
pf cohort
pf mean catheterization
ph
pharmaceut
pharmacologic management
pharmacologic studies
pharmacologic therapies
pharmacologic treatment
pharmacological armamentarium
pharmacological treatment
phenylephrine
phenylephrine-induced genes
phenylephrine-mediated hypertrophy of cardiomyocytes
phosphocreatine
phosphodiesterase-2
phospholamban
phosphomimic ser77
phosphorylation
physical activity
physical activity control
physical examination
physical exhaustion
physical therapy
physical volume
physician
physician adherence
physician continuity
physician follow-up after discharge
physician volume
physicians
physio ring 30
physiologic processes
physiological
physiological proteolysis
pigs
pioglitazone
pka
pka subunits
pkc-βii
pkc-βii-ser
placebo
placebo groups
placebo-controlled clinical trial
placebo-treated patients
plasma
plasma b-type natriuretic peptide
plasma catecholamines
plasma membrane translocation
plasma n-terminal pro-b-type natriuretic peptide
plasma norepinephrine
plasma nps
plasma of heart failure patients
plasma samples
plasticity
plateau phase of ventricular action potentials
platelet-activating factor
pleasanton
pluripotency marker nanog
pna
pneumonia
poc measurement
point-of-care systems
pol ii
policy recommendations
polymorphisms
polytetrafluoroethylene tube
poor myocardial function
poorer vo2
population-based
population-based rotterdam study
population-specific health interventions
porcine model of right heart failure
portal hypertension
positron emission tomography imaging
post-acute care transfer policy
post-dash/srd brachial
post-hct chf
post-lvad ai
post-myocardial infarction heart
post-myocardial infarction heart failure patients
post-myocardial infarction patients
post-pd initiation
post-translational
post-transplant morbidity
posterior wall infarction
posteriorly displaced papillary muscles
postexercise phosphocreatine resynthesis
postischemic heart failure
postmarketing trials
postmenopausal women
postnatal mammalian myocardium
postoperative
postoperative echocardiography
postoperative mortality
postoperative normalization
postoperative normalization of albumin levels
postoperative survival
postoperatively secondary
potassium
potent inhibition
power spectral analysis
ppr
practice settings
practice-level differences
practice-level variation
pre-crt lv end-diastolic dimension index
pre-hct chest radiation
pre-hct exposure to anthracyclines
pre-hct germline dna
pre-pd
precapillary ph
precapillary pulmonary hypertension
precipitating factor
predicting crt response
prediction rule
predictor
predictors of esrd
predictors of mortality
preoperative albumin
preoperative clinical
preoperative demographics
preoperative hypoalbuminemia
preoperative renal dysfunction
preoperative serum albumin levels
prescribed therapy
prescribing guideline-recommended medications
prescriptive 4-year survival
preserved
preserved cardiac index
preserved ef
preserved ejection
preserved ejection fraction
preserved ejection fraction after myocardial infarction
preserved ejection fraction outcomes trial
preserved left ventricular
preserved left ventricular ejection
preserved left ventricular ejection fraction
preserved lv ejection fraction
preserved mitral valve opening
preserved systolic function
pressure development
pressure gradient
pressure ulcers
pressure volume relation
pressure-overload hypertrophy
pressure-overload-induced heart failure
pressure-overload-induced hypertrophy
pressure-volume conductance catheter system
prevalent coronary heart disease
prevention strategies
primary composite endpoint
primary endpoint
primary outcome
primary outcome of death
principal discharge diagnosis
prior stroke score
pro-adrenomedullin
pro-brain natriuretic peptide
pro2-leu3
pro6-gly7
pro75-arg76
proangiogenic effects
process redesign framework
processes of care
processes of care delivery
progenitors
prognosis
prognostic benefit
prognostic factors
prognostic power
programmed cell death
progress in anticoagulation
progression to heart failure
progressive disease
progressive loss of fat free mass
prolapse
prolapse of degenerative mitral valve
pronto
propensity score
propensity score decile
propensity-score
propranolol
prostate
protective peptides szeto-schiller
protein content
protein expression
protein kinase
protein kinase r-like er kinase
protein levels
proteins
proteome of hdl particles
proteomic remodeling
protocol-driven poc testing
province of alberta
proximal circumflex artery
proximal lad
proximal lad model
proximal lcx
proximal left anterior descending
proximal left anterior descending artery
psoriasis
psoriasis patients
psss
psychometric testing
psychosocial factors
psycinfo
public health
public health problem
publicly reported 30-day risk-standardized mortality
pulmonary
pulmonary arterial
pulmonary arterial hypertension
pulmonary arterial systolic pressure
pulmonary arterial systolic pressure relationship
pulmonary arterial vascula
pulmonary arteries
pulmonary artery
pulmonary artery snared
pulmonary capillary wedge pressure
pulmonary congestion
pulmonary embolectomy
pulmonary embolism
pulmonary hypertension
pulmonary hypertension patients
pulmonary vascular resistance
pulsatile afterload
pulse-wave velocity
pulseless ventricular fibrillation
pump exchanges
pump failure
pump malfunctions
pump thrombosis
pump-exchange technique
pure epicatechin
purely hemodynamic disorder
pvf
pyridostigmine
pyridostigmine administration
q65p
q66p
qol
qr
qrs
qrs duration
qrs morphology
qrs prolongation
qrs width
qt intervals
qt variability
qtv
qtv normalized
quality
quality improvement database
quality improvement initiative
quality of care
quality of care programme
quality of life
quality of life assessment
quality-of-life score
quality-of-life scores
quantitative proteomics
québec health insurance board databases
ra
raas
race
rad
rad on cav1.2
rad q65p
rad q66p
rad q66p limits
rad variant
radial arterial tonometry
radial artery tonometry variables
radial strain
radioenzymatic-
radiological signs
raf-mek1/2-erk1/2 scaffold proteins
raf-mek1/2-erk1/2 signalling pathway
raised blood glucose levels
raloxifene
raloxifene-treated
ramirez-sanchez
randomised-controlled trials
randomized trial
randomized trials
ranked hospitals
rapid r-r interval oscillations
rapid right ventricular pacing
ras
ras axis
ras blockers
ras-
ras-blocker uptitration
rat
rat left ventricular
rat metabolic risk
rate constant
rate control
rate of death
rate-control
rate-control patients
rate-control strategies
rate-control treatment strategies
rates
ratio of phosphocreatine to atp
ratio of systolic blood pressure
ratios
rats
rats enhanced pde2 expression
rcts
re-hospitalization
readmission
readmission metric
readmission metrics
readmission rate
readmission rates
readmissions
readmissions in heart failure
receiver operating characteristic curve
receptor antagonist
receptors
recharged
recipients
recipients bridged to transplantation
reciprocal regulation
reclassification of risk
recommendations
recommended target dose
recommended therapies registry
recovery
recovery period of low bp
recruitment
redo sternotomy
reduced
reduced ef
reduced ejection
reduced ejection fraction
reduced mortality
reduced quality of life
reduction
ref
refill compliance
refractory
refractory cardiogenic shock
refractory congestive heart failure
regional circumferential strain
regression models
regulate expression of target genes
regulation
regulation of feeding
regulator of growth
regulatory
regulatory subunit
rehabilitation
rehospitalization
relative appendicular lean mass index
relative risk (rr
relative risk among trials
relative wall thickness
relax-ahf
relaxation/viscoelastic
religious beliefs
rem
rem2
remodeling in heart failure
remote ischemic conditioning
remote monitoring
renal
renal artery stenosis
renal atherosclerotic lesions
renal denervation
renal disease
renal dnx
renal dysfunction
renal function
renal impairment
renal optimization strategies evaluation
renal underperfusion
renastur cohort
renin- angiotensin-aldosterone pathway
renin-angiotensin system
renin-angiotensin system blocker
renin-angiotensin-aldosterone
renin-angiotensin-aldosterone system
renin-angiotensin-aldosterone system inhibitors
reoperation
repeat ed visits
reperfusion therapy
repolarization instability
repolarization lability
report
reporting
research investigations
research studies
residual confounding
resistance training
resistant hypertension
resistin
resistin correlated
resistin levels
resource
resource use
respiratory gas analysis
response after cardiac resynchronization therapy
resting hemodynamics
resting hr
resting tension (fpassive-sarcomere length relations
restrictive red blood cell transfusion strategy
resynchronization reverses remodeling
resynchronization-defibrillation
resynchronization-defibrillation for ambulatory heart failure trial
retention trial
retrospective
retrospective cohor
retrospective cohort
revascularization
reverse
reverse cardiac remodeling
reverse remodeling
reverse remodeling after crt
reverse remodeling parameters
reversibility
reversible myocardial ischemia
reviews and dissemination
rgk
rgk protein
rheumatic
rheumatic fever
rheumatoid arthritis
rhythm
rhythm control therapy
rhythm-
rhythm-control
ri
right atrial area
right atrial mass removal
right atrial myxoma
right atrial pressure
right atrium
right atrium mass
right coronary artery
right heart circulation
right heart circulatory failure
right heart failure
right heart filling pressures
right ventricle
right ventricle overload
right ventricular
right ventricular contractile function
right ventricular contractile reserve
right ventricular end-diastolic area index
right ventricular fractional area change
right ventricular function
right ventricular pressure overload
right ventricular support
right ventricular-pulmonary arterial coupling
right-sided cardiac catheterization
riiα
ring annuloplasty
risk
risk factors
risk for heart failure
risk for hospitalized heart failure
risk of death
risk of event
risk of heart disease
risk of heart failure
risk of hf
risk of incident cvd
risk of long-term mortality
risk predictor
risk reduction
risk stratification
risk stratification models
risk stratification of cardiac patients
risk-adjusted all-cause mortality
risk-adjusted mortality
riα
rm
rm trended
rmsea
rna polymerase ii
robot-assisted gait therapy
robot-assisted training
rose
rr intervals
rrna transcription
rs
rs synchrony
rtq-pcr
rv
rv dysfunction
rv failure
rv function
rv function evaluation
rv support
rvpo
rwt
s s2
s'lateral
s'septal
s12884
s1pr1
s1pr1 agonist
s1pr1 downregulation
s1pr1 reciprocal downregulation
s1pr1s
s3991
sa
sa in predicting adverse cv events
saf
saf cohort
safety
salt
salt loading
sandwich alphalisa
sarcomere shortening
sarcomeric microstructure
sarcoplasmic reticular
saxagliptin
scaffold protein drives
schfi
schfi v.6.2
sci
scientific literature
scn5a
scn5a electric remodeling
scn5a transcript
scn5a variants
score
sd
sd testosterone levels
sdqt
seattle heart failure model-predicted survival
secondary outcome of death
secondary study
selective beta-blockers
self-care confidence
self-care confidence scale
self-care education
self-care maintenance
self-care maintenance scale
self-care management
self-care management scale
self-care of heart failure index
self-reported physical activity
sepsis
septal defects
septal wall cs
septum
sequence-specific binding
sequential phosphorylation
ser23/24 troponin i phosphorylation
ser77
ser83
ser83 mutant riα proteins
ser83 phosphorylation
serial evaluation
serial measurements
serum levels
serum potassium
serum potassium level
serum resistin levels
serum sodium levels
severe ai
severe anemia
severe cad
severe end-stage hf
severe frailty
severe heart failure
severe hyperkalemia
severe hypertension
severe hyponatremia
severe ischemia
severe systolic heart failure
severe systolichf
severely reduced lvef
sex
sex-adjusted risk
sex-matched
sex-specific model
sh
sham
sham group
sham levels
sham-dnx
sham-innervated
sham-inv
sham-operated
sham-operated animals
shift
shock therapy
short-form quality of life domains
short-term fractal scaling exponent
short-term mortality rates
shortened lvet
shortness of breath due to lung congestion
shotgun lc-ms/ms
shunt implants
shunts
shuttle walk test
sickle cell disease
signal transduction cascade
signaling paradigms
signaling pathway
signaling pathways
signalling cascades
signalling pathways
signalling protein
signalosome complex
single-arm
single-cohort study
sinus rhythm
sitagliptin
skeletal muscle
skeletal muscle abnormalities
skeletal muscle mass
skeletal muscle mass assessed
skeletal muscle mass correlated
skeletal muscle mass t-score
skeletal muscle sarcomere structure
skinfold thickness
skm
skm biopsies
skm mitochondrial structure
slow hf evolution
slowed conduction
slowness
smad 2/3
small-molecule inhibitors
smoked
smoking
smoking cessation
snp rs10927887
social mandate
social support
sodium-restricted dash diet
sodium-restricted dietary
solid ehrlich carcinoma
soluble guanylate cyclase
soluble st2 in ambulatory patients
sonographic
south dakota
southeastern minnesota
spearman correlations
speckle tracking echocardiography
spectral
sphingosine-1-phosphate
sphingosine-1-phosphate receptor 1
spironolactone
spironolactone dose
spontaneous cardiac dysfunction
spontaneous ventricular tachycardia
spontaneous vt
sprague-dawley rats
sr
sr ca(2+)-pump
sr ca(2+)-pump function
ss20
sst2
sst2 concentrations
sst2 measurement
sst2 titrated
sst2 values
sst2/low-dose bb
st-segment-elevation mis
st2
st2 levels
stabilized chronic heart failure
stable coronary artery disease b-type natriuretic peptide
stable heart failure patients
stage i-iii breast cancer
standard cardiac rehabilitation
standard care
standard criteria cardiac transplant recipients
standard diuretic therapy
standard error
standard error of measurement
standard heart failure medicines
standardized exercise protocol
standardized nursing terminologies
standing blood pressure
statistical
statistical standards
statitistical
ste
stem cell source
stent coated
stenting
stop hypertension diet
strain
strain rate
strategy
strength of race
stress conditions
stress doppler echocardiography
stress echocardiography
stretch rate
stroke
stroke prevention trial
stroke volume
structurally normal hearts
structure
structured telephone support (sts
sts
sts hh
sts hm
student t test
study closure
study design
study-related
subcellular alterations
subclinical atherosclerosis
subpulmonary ventricle
subscales
subunit expression
suburban hospitals
subvalvular
sudden
sudden cardiac death
sudden cardiac deaths
sudden death
sulfonylureas
surgery
surgical indication
surgical method of transverse aortic constriction
surgical patients
surgical revascularization
surgical ring implantation
surgical tactics
surgically induced myocardial infarction
surrogates
survival
survival projections
survival study
survival study in heart failure
surviving left ventric
sustainability
svr index
swedish national inpatient registry
swedish web-system for enhancement and development of evidence-based care in heart disease
swine
swine model of tachycardia-induced heart failure
sympathetic
sympathetic activity
sympathetic control of heart rate
sympathetic nervous systems
sympathetic outflow
sympathetic tone
sympathovagal balance
symptom limited maximal cpet
symptomatic adult fontan
symptomatic chronic advanced heart failure patients
symptomatic systolic heart failure
syndrome
syndrome of right heart failure
systematic review
systemic adverse events evaluation
systemic blood pressure
systemic hypertension
systemic vascular resistance
systemic/uv
systems proteomics
systole
systolic
systolic blood pressure
systolic dysfunction
systolic elastance
systolic function
systolic heart failure
systolic heart failure treatment
systolic hf
systolic hf of unclear etiology
systolic human heart failure
systolic left ventricular dysfunction
systolic mitral annulus velocity
systolic murmurs
systolic pressure
systolic ventricular function
t interventions
t1 changes
t1 mapping
t1 time
t1-mapping mri
t1-mapping sequence
t1-mapping technique
t24/7
t2d
t2d consumed erc
tac
tac surgery
tac-
tac-induced heart failure
tac-induced proteomic alterations
tachy-
tachycardia
tachycardic response
tachypacing-induced hf
tapse
tapse-to-pasp ratio
tapse/pasp
target sodium
taub
taxonomy
technical advisors
telehealth
temporal incidence
temporal trends
temporary centrimag rvad
terminal heart failure
terminal phase
tertiary referral centre
test-retest reliability
testosterone
testosterone group
testosterone supplementation
testosterone therapy
tgf-β
tgf-β inhibition
tgf-β receptor type i
tgf-β signaling
tgtttmena mice
thalassaemia
therapeutic
therapeutic functions
therapeutic interruption of activated neurohormonal systems
therapeutic left-to-right interatrial shunting
therapeutic targets
therapeutic treatment
therapy
therapy refractory cardiogenic shock
thickness
thigh muscle
third heart sound
thirty-day mortality
thoratec corp
three-year hf hospitalization
thromboembolic events
thrombosis
thrombotic obstruction
tidal respiration
time domain heart rate variability
time to death
time to esrd
time-dependent analysis
time-dependent covariates
time-domain
time-varying seattle heart failure
timed up & go
timed up & go test
timing of myocardial infarction
tissue doppler imaging
tissuefaxs technology
titin
titin hypophosphory
titin hypophosphorylation
titin isoforms
titin modification
tnf antagonist
tnf antagonists
tnfα
to death
tobacco
tolvaptan
total adiponectin
total cholesterol
total symptom domains
toxicity
tpse
traditional heart failure
traditional myocardial delayed enhancement imaging
training-induced changes
trans
transcatheter
transcatheter aortic valve procedure
transcription
transcription factor dhand
transcription factor gata4
transcription factor hand2 in heart failure
transcription factors
transcriptional analysis
transcriptional pause release
transduction pathways
transforming growth factor beta-dependent yield
transfusion thresholds
transfusions
transgenic
transgenic mice
transient receptor potential cation channel m7
transitions of care program
transmitral e-wave/early diastolic mitral annular velocity
transmitral flow velocities
transoesophageal echocardiographic
transoesophageal echocardiography
transplant
transplant ineligible patients
transplant pool
transplant process
transplant-ineligible patients
transplantation
transplantation eligibility status
transseptal catheterisation
transthoracic echocardiography
transverse aortic constriction
trastuzumab
trastuzumab use
trastuzumab-related cardiotoxicity
trastuzumab-related chf
trastuzumab-treated patients
trastuzumb-related chf
treadmill exercise testing
treadmill testing
treatment
treatment algorithms
treatment heart failure
trends
trial
trials
triangular resection
trichrome blue histologic
tricuspid annular plane systolic excursion
tricuspid valve
trigger hemoglobin threshold
troponin t
trpm7) channel mrna
truncated channels
truncated na+ channels
tta/tgttttmena
tta/tgttttmena mice
tta/ttttmena
tta/tttttmena mice
tug test
tumor necrosis factor
tunel
tunel assay
tunel-positive cells
tuscany
twist
two-vessel disease model
type 2 diabetes
u.s. food and drug administration
udirectional left-to-right interatrial shunting
uha class iii
uk
ultrastructural
um cohort
um/va/va-rt cohorts
unclear etiology
uncontrolled hypertension
underlying heart disease
unfavorable outcome
unfit
unfolded protein response
unfolded protein response regulates cardiac sodium current
unilateral
unilateral renal denervation
unilateral renal dnx
uninephrectomy
unintentional weight loss
unit costs
units accustomed
university health network
university of connecticut health center
university of connecticut heart failure center
university of michigan hf clinic
unloading of the heart
unplanned admission
unplanned readmission
untranslated region of messenger rna
untreated acf groups
upr
upr effectors
upregulated transforming growth factor-β
uptake of class i cpg recommendations
uptitration
urgent all-cause readmission
urgent cardiac transplant
urgent readmission
us healthcare programmes
usual care
uti
utilization
va health care systems
va-rt cohort
vad
vad group
vad groups
vagal
vagal tone
validation studies
validity
valve plasty
valvular
valvular disease
valvular regurgitation pulmonary embolism
vascular effects
vascular endothelial growth factor
vascular endothelial growth factor blockade
vascular stiffness
vasodilator effects
vasodilators
vasopeptidase inhibitors
vasopressin
vasopressin receptor antagonist
vasopressin receptor antagonist therapy
vegetables
vegf
vegf inhibition counteracted
vegf signaling pathway
vegfr2
vehicle
velocity of circumferential shortening
velocity time integral
ven/vco2 slope
vena cava
venoarterial dilation
ventilatory efficiency slope
ventricular
ventricular action potential duration
ventricular assist device
ventricular assist device support
ventricular assist devices
ventricular cardiomyocytes
ventricular diastolic function
ventricular dysfunction
ventricular ejection fraction
ventricular mass
ventricular power index
ventricular structure
ventricular tachycardia
ventricular wall stress
ventricular-arterial coupling
ventricularly paced
veterans aged 50 years
video edge detection
virtual cohorts
vo
vo2
vo2max
voltage-gated cardiac na+ channel α-subunit
volume overload
voluntary testimonies
von willebrand factor
vt
vvd
vvd variation
vvd variations
walk test (6-mwt
wall stiffness
wall stress
wasting
weak grip strength
web-based simulation tool
weight
weight loss
well-treated cohort of ambulatory patients
western australian linked administrative health data
western blot
western blot analysis
western blots
western society
white rabbits
whole grain intake
wilcoxon matched-pairs signed-rank tests
wild type
wild-type littermates
wild-type rad
withdrawal of sympathetic tone
witness
women
women' health initiative
workload
world health organization website
wrf
writer
wstar-kyoto
wt
wt riα
xanthine oxidase
xanthine oxidase inhibition
xo
xo inhibition
xo-mediated ros
xo-mediated ros effects
yorkshire swine
young normal reference mean
young woman
zebrafish
zsf1 rats
α-myosin heavy chain
β-adrenergic receptor agonist
β-adrenergic receptor blockade
β-adrenergic receptor blocker therapy
β-adrenoceptor blockade
β-ar
β-ar drive
β-ar responsiveness
β-blockade
β-blocker
β-blocker dose increase
β-blocker metoprolol
β-blocker uptitration
β-blocker uptitrations
β-blocker-induced enhancement
β-blockers
β-myosin heavy chain
β1-adrenergic receptor
β1ar
β1ars
β2-adrenergic receptor haplotype
β2-receptor
